Earlier this week we announced the launch of the new iDSI website: a platform that highlights our work helping low and middle income countries to achieve sustainable, good quality healthcare and also provides a place for our experts to weigh in on current events in the global health community on our blog. Our Impact The second feature of the new …
iDSI launches new communication platforms for the global health community
We’re very excited to announce that iDSI has a new and much improved website! We believe that the new site will better serve the global health community: providing access to key resources to support the advancement of healthcare systems and connecting people with our network of health economists and global health experts. You can find our website at the same …
The NICE threshold: How much is too much? Who decides?
Prof Karl Claxton, University of York, and colleagues have argued that NICE is advising the UK National Health Service “to pay too much” for new drugs. NICE typically recommends treatments for use in the NHS where their cost-effectiveness falls below the threshold of around £20,000 and £30,000 per QALY gained (quality-adjusted life year). New research led by Claxton suggests that paying more …
The Gates Reference Case is launched at the Houses of Parliament, London
NICE International launches the Gates Reference Case, a principle-based standardised methodology for good practice in the planning, conduct and reporting of economic evaluation for informing priority setting in health.